EA201190133A1 - Оптически активные производные 3-[(фенилпиперазин-1-ил)алкил]-3-алкил-оксиндола, обладающие активностью в отношении центральной нервной системы (цнс) - Google Patents

Оптически активные производные 3-[(фенилпиперазин-1-ил)алкил]-3-алкил-оксиндола, обладающие активностью в отношении центральной нервной системы (цнс)

Info

Publication number
EA201190133A1
EA201190133A1 EA201190133A EA201190133A EA201190133A1 EA 201190133 A1 EA201190133 A1 EA 201190133A1 EA 201190133 A EA201190133 A EA 201190133A EA 201190133 A EA201190133 A EA 201190133A EA 201190133 A1 EA201190133 A1 EA 201190133A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
nervous system
central nervous
phenylipiperazin
oxindol
Prior art date
Application number
EA201190133A
Other languages
English (en)
Other versions
EA018981B1 (ru
Inventor
Балаж Вольк
Йожеф Баркоци
Иштван Гачайи
Элемер Фогашши
Йожеф Шиндлер
Габор Гиглер
Хайналка Компагне
Дьёнош Ильдико Надьне
Каталин Паллаги
Марта Порч-Маккаи
Габор Сенаши
Тибор Мезеи
Дьюла Лукач
Дьёрдь Леваи
Андраш Эдьед
Ласло Габор Харшинг
Original Assignee
Эгиш Дьёдьсердьяр Ньильваношан Мюкеде Ресвеньтаршашаг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьёдьсердьяр Ньильваношан Мюкеде Ресвеньтаршашаг filed Critical Эгиш Дьёдьсердьяр Ньильваношан Мюкеде Ресвеньтаршашаг
Publication of EA201190133A1 publication Critical patent/EA201190133A1/ru
Publication of EA018981B1 publication Critical patent/EA018981B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Настоящее изобретение относится к энантиомерам 5,7-дихлор-3-{4-[4-(4-хлорфенил)пиперазин-1-ил]бутил}-3-этил-1,3-дигидро-2Н-индол-2-она формулы (II), их фармацевтически приемлемым солям, способу их изготовления, лекарственным продуктам, содержащим указанные энантиомеры, и применению их и их фармацевтически приемлемых солей для лечения заболеваний центральной нервной системы.
EA201190133A 2009-02-06 2010-02-05 Оптически активные производные 3-[(фенилпиперазин-1-ил)алкил]-3-алкилоксиндола, обладающие активностью в отношении центральной нервной системы (цнс) EA018981B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0900071A HUP0900071A2 (en) 2009-02-06 2009-02-06 Optically active 3-[(phenyl-piperazin-1-yl)alkyl]-3-alkyl-oxindole derivatives influencing the central nervous system and pharmaceutical compositions containing them
PCT/HU2010/000014 WO2010089616A1 (en) 2009-02-06 2010-02-05 Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activity

Publications (2)

Publication Number Publication Date
EA201190133A1 true EA201190133A1 (ru) 2012-02-28
EA018981B1 EA018981B1 (ru) 2013-12-30

Family

ID=89988765

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190133A EA018981B1 (ru) 2009-02-06 2010-02-05 Оптически активные производные 3-[(фенилпиперазин-1-ил)алкил]-3-алкилоксиндола, обладающие активностью в отношении центральной нервной системы (цнс)

Country Status (6)

Country Link
US (1) US20120108607A1 (ru)
EP (1) EP2393778B1 (ru)
JP (1) JP2012517413A (ru)
EA (1) EA018981B1 (ru)
HU (1) HUP0900071A2 (ru)
WO (1) WO2010089616A1 (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
NZ551547A (en) 2004-05-11 2010-06-25 Egis Gyogyszergyar Nyrt 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2H-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders

Also Published As

Publication number Publication date
EP2393778B1 (en) 2014-04-09
EP2393778A1 (en) 2011-12-14
JP2012517413A (ja) 2012-08-02
EA018981B1 (ru) 2013-12-30
WO2010089616A1 (en) 2010-08-12
HUP0900071A2 (en) 2010-10-28
US20120108607A1 (en) 2012-05-03
HU0900071D0 (en) 2009-03-30

Similar Documents

Publication Publication Date Title
CY1121847T1 (el) Παραγωγα 1-((3-((1-πιπεραζινυλο)καρβονυλο)φαινυλο)μεθυλο)-2,4(1η,3η)-κιναζολινοδιονης ως αναστολεις parp για τη θεραπεια του καρκινου
MA37405A1 (fr) Composés hétérocyclyle
NZ622769A (en) Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
EA201071144A1 (ru) Гетероциклические производные
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
EA201590345A1 (ru) Способы лечения рака с использованием 3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона
EA201070598A1 (ru) Терапевтическое применение соединений, обладающих комбинированной активностью в отношении sert, 5-htи 5-ht
MX2014013696A (es) Derivado de pirazol y uso del mismo para propositos medicos.
MX2013008056A (es) 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2).
NZ601121A (en) 5-alkynyl-pyrimidines
NZ599513A (en) Compounds for the treatment of dyslipidemia and related diseases
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
MX2015002511A (es) Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos.
MX2010007714A (es) Piridinas fusionadas activas como inhibidores de c-met.
PE20141167A1 (es) Piridopirazinas sustituidas como inhibidores novedosos de ptk
EA201000557A1 (ru) Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств
EA201000486A1 (ru) Ингибитор белка, активирующего 5-липоксигеназу (flap)
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
NZ612544A (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
EA201100623A1 (ru) Сульфоксиминзамещенные анилинопиримидиновые производные в качестве cdk ингибиторов, их получение и применение в качестве лекарственных средств
PH12015500012A1 (en) Benzodioxole derivative and preparation method and use thereof
NZ611529A (en) Glucagon receptor modulators

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU